Barbara Slusher, Ph.D., M.A.S.

Director, Johns Hopkins Drug Discovery, Professor, Neurology, Psychiatry, Neuroscience, Medicine and Oncology , Johns Hopkins University School of Medicine

At Johns Hopkins, Dr. Slusher leads the largest integrated drug discovery program on campus with a veteran team of medicinal chemists, assay developers, pharmacologists, toxicologists, and pharmacokinetics/drug metabolism experts with an average of 15 years Pharma R&D drug discovery experience. The team is engaged in identifying novel drug targets arising from the faculty’s research and translating them into new drug therapies for clinical development. Dr. Slusher has published over 190 scientific articles and is the inventor on over 80 patents and applications. She is a co-founder of Cerecor, a CNS-focused biopharma company, and most recently Dracen Pharmaceuticals, focused on immuno-metabolism. She also founded and is leading the first-ever International Consortium of Academic Drug Discovery (www.addconsortium.org) with over 140 university-led translational centers and 1500 members in an effort to coordinate and enhance academic drug discovery efforts.